首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS, METHOD FOR PREVENTING OR TREATING DIABETES MELLITUS, AND METHOD FOR SCREENING FOR DIABETES MELLITUS THERAPEUTIC AGENT

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS, METHOD FOR PREVENTING OR TREATING DIABETES MELLITUS, AND METHOD FOR SCREENING FOR DIABETES MELLITUS THERAPEUTIC AGENT

机译:用于预防或治疗糖尿病的药物组合物,用于预防或治疗糖尿病的方法以及用于筛查糖尿病的治疗剂的方法

摘要

Provided are a pharmaceutical composition for preventing or treating diabetes mellitus, containing geraniol or a pharmaceutically acceptable salt thereof as an active ingredient, a method for preventing or treating an individual with diabetes mellitus, comprising a step for administering a pharmaceutical composition, containing geraniol or a pharmaceutically acceptable salt thereof as an active ingredient, to an individual and a method for generating an olfactory stimulus in the individual by the composition, and a method for screening for a diabetes mellitus therapeutic agent, comprising the steps of: making a test material come into contact with a cell expressing an olfactory receptor; measuring the expression extent of glucagon-like peptide-1 (GLP-1) secreted in the cell; and determining that the test material is a candidate material for a diabetes mellitus therapeutic agent when the test material promotes the expression of GLP-1. In addition, provided are a quasi-drug composition and a cosmetic composition for preventing or alleviating diabetes mellitus, containing geraniol.
机译:提供用于预防或治疗糖尿病的药物组合物,其包含香叶醇或其药学上可接受的盐作为活性成分,一种用于预防或治疗患有糖尿病的个体的方法,其包括用于施用药物组合物的步骤,所述药物组合物包含香叶醇或作为活性成分的药学上可接受的盐,对个体以及通过该组合物在个体中产生嗅觉刺激的方法,以及用于筛选糖尿病治疗剂的方法,包括以下步骤:制备测试材料与表达嗅觉受体的细胞接触;测量分泌在细胞中的胰高血糖素样肽-1(GLP-1)的表达程度;当所述测试材料促进GLP-1的表达时,确定所述测试材料为糖尿病治疗剂的候选材料。另外,提供了含有香叶醇的准药物组合物和用于预防或减轻糖尿病的化妆品组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号